Search results
-
Blog
Case Study: How Altasciences Launched a Phase I Study 70% Faster Than the Industry Standard
Discover how Altasciences reduced clinical trial start-up timelines by 70%, initiating the first dose of a Phase I MAD study in just 3.5 weeks.
-
Blog
Exploring the Advantages of Canada for Early-Phase Clinical Trials
Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.
-
Blog
Webinar: Assessing Cognition Impairment Using Driving Simulators in Clinical Trials
Learn more about how Altasciences can test cognition, and the impact of driving under the influence of medication, using our state-of-the-art driving simulators.
